Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were found to help increase hair growth and decrease hair loss.

Taking too many vitamin and mineral supplements can cause serious health problems.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Lower melatonin levels are linked to more skin aging.

Nutrition is important for skin health, and changing diet can help prevent and treat skin diseases.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Cynomorium songaricum has many health benefits and could help with hair regrowth.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Fear of hair-related issues causes significant mental distress, especially in high-stress women.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Some supplements and hormones can increase hair loss by raising DHT levels.

Certain micronutrients may improve hair and nail health, but more research is needed to confirm their benefits.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.